british pharmacopoeia 1988
developments, emerging therapies, and changing regulatory landscapes. Major revisions include: Incorporation of new monographs for biologics and advanced therapies. Adoption of modern analytical techniques such as HPLC and mass spectrometry. Enhanced emphasis on Good Manufacturing